Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection
Clinical trial NCT00362635 · COMPLETED
Trial details
- NCT number
- NCT00362635
- Sponsor
- Bukwang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2011-12-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.